Bare Metal Stents Market Size - By Product (Self-expandable, Balloon Expandable), Material Type (Stainless Steel, Cobalt-Chromium Alloy, Nitinol), Application (Coronary, Peripheral), End-use (Hospitals, ASCs) & Forecast, 2023 – 2032

Bare Metal Stents Market Size

Bare Metal Stents Market size was anticipated to be worth over USD 434 million in 2022 and it is expected to reach around USD 567.1 million by 2032, witnessing an 2.8% growth rate over the forecast period. The market is influenced by several pointers, including factors or conditions stimulating industry growth, owing to increasing incidence of coronary artery disease, rising advancements in stent design and materials, growing aging population, and increasing awareness among others.

In addition, BMS are often more cost-effective than their drug-eluting counterparts because they don't require the extended use of expensive antiplatelet medications. This cost-effectiveness can be particularly appealing in regions with limited healthcare budgets.Moreover, in numerous countries, healthcare reimbursement policies play a significant role in determining the adoption of medical devices like bare metal stents. Favorable reimbursement policies can encourage healthcare providers to choose stents as a treatment option for coronary artery disease, thereby boosting market progress.

Bare metal stent (BMS) is a medical device used in the field of interventional cardiology and vascular surgery to treat narrowed or blocked blood vessels, typically arteries, in a procedure called angioplasty. It is a metallic scaffold, usually made of stainless steel or other biocompatible metals, designed to be implanted permanently within a narrowed blood vessel to help restore blood flow.

COVID-19 Impact

The COVID-19 pandemic significantly impacted the bare metal stents market, causing a notable shift in demand and dynamics. As the healthcare systems around the world were overwhelmed with managing the outbreak, elective procedures, including non-urgent stent placements, were postponed or cancelled to prioritize COVID-19 patients and reduce the risk of infection. This led to a decline in the immediate demand for bare metal stents.

Moreover, disruptions in the supply chain, manufacturing delays, and limitations on transportation posed challenges in the production and distribution of these medical devices. The economic downturn resulting from the pandemic also affected healthcare budgets and patient affordability, further impacting the demand for stents. However, as the number of cases declined, the demand for BMS surged in the following years.

Bare Metal Stents Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Key trends in the market includes increasing demand for self-expandable stents, rising advancements in stent design and materials continue to improve the performance of BMS. This includes the development of stents with thinner struts, improved radial strength, and better flexibility, that can enhance safety and patient outcomes. Additionally, there is increasing interest in tailoring stent choices to individual patient characteristics. This involves selecting the most appropriate stent type, size, and material based on a patient's unique clinical profile to optimize outcomes and minimize complications.

Furthermore, the market is expanding in emerging economies as healthcare infrastructure improves and access to interventional cardiology procedures increases. Thus, growing middle-class population and rising awareness of cardiovascular health in these regions contribute to market expansion.

Bare Metal Stents Market Restraint Factor

The higher risk of stent thrombosis is a key restraint in the market. Bare metal stents lack a drug-coated coating unlike DES, which releases pharmaceuticals that reduce cell development and lessen the danger of restenosis. BMS rely only on their mechanical scaffold to maintain the artery open. This suggests that BMS do not actively inhibit tissue expansion (neointimal hyperplasia) within the stent, which is a typical problem following stent insertion. Moreover, patients who receive BMS are typically prescribed antiplatelet medications (such as aspirin and clopidogrel) to reduce the risk of stent thrombosis. However, some patients may not adhere to their medication regimen or may discontinue antiplatelet therapy prematurely, increasing the risk of clot formation.

Bare Metal Stents Market Analysis

Based on product, the bare metal stents market is segmented as self-expandable stent, and balloon expandable stent. In 2022, the balloon expandable stent segment accounted for the largest share of around 56% in market. One of the main advantages of balloon-expandable stents is its ability to be precisely sized and implanted at the desired location. These stents are placed on a balloon catheter and inflated within the vessel to the appropriate size. These precise dimensions and placement ensure that the stent completely covers the lesion (narrowing or blockage) and adapts to the vessel walls. In addition, balloon-expandable stents are frequently selected in conditions demanding precise stent insertion, such as coronary artery procedures.

Based on material type, the bare metal stents market is segmented as stainless-steel stents, cobalt-chromium alloy stents, and nitinol. The cobalt-chromium alloy stents segment accounted for the significant share of 50.9% in market. Cobalt-chromium alloys offer excellent radiopacity, making the stent highly visible under fluoroscopy and other medical imaging techniques. Enhanced visibility helps interventional cardiologists precisely position and deploy the stent within the target lesion. Moreover, it exhibits good flexibility and conformability, allowing them to navigate through tortuous anatomies and accommodate changes in vessel diameter.

 Based on application, the bare metal stents market is segmented as coronary artery disease, peripheral artery disease, and others. The coronary artery disease segment accounted for the largest share of 70.4% in market and is expected to record robust growth during the forecast period. Coronary artery disease is one of the most prevalent cardiovascular diseases globally. It affects millions of people, particularly in developed countries with lifestyle-related risk factors such as sedentary lifestyles, unhealthy diets, and smoking. The high prevalence of CAD leads to a substantial patient population in need of coronary interventions, including stent placement.

Based on end-use, the bare metal stents market is segmented as hospitals, ambulatory surgical centers, and others. The hospitals segment held a dominant business share of over 79% in 2022 and is expected to grow at a CAGR of 2.7% between 2023 to 2032. Hospitals are the primary healthcare institutions where coronary interventions, such as stent placements, are performed. Coronary artery disease (CAD) is a prevalent cardiovascular condition that requires medical attention, and hospitals are the primary facilities for diagnosing and treating patients with CAD. The high volume of coronary interventions conducted in hospitals creates a substantial demand for BMS.

North America bare metal stents market accounted for significant revenue in 2022 and is expected to reach over USD 112.4 million in 2032 with a CAGR of 1.6% from 2023-2032. North America boasts some of the most advanced healthcare infrastructure and facilities in the world. State-of-the-art hospitals, specialized cardiac centers, and a well-developed healthcare ecosystem make it a key region for the diagnosis and treatment of cardiovascular diseases.

Moreover, North America has among the highest healthcare spending globally. This significant investment in healthcare infrastructure, along with research, and development activities supports the adoption of advanced medical devices like BMS and ensures their widespread availability, leading to the regional expansion.
 

Bare Metal Stents Market Share

Some of the major market players operating in the bare metal stents market are:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biosensors International Group
• Sahajanand Laser Technology Limited
• Andramed GmbH
• Meril Life Science
• GENOSS Co., Ltd.,
• Boston Scientific Corporation
• Cook Medical 
• Medtronic Plc.

These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Bare Metal Stents Industry News:

• In June 2023, W. L. Gore & Associates announced the Gore VBX forward Clinical Study, that will evaluate the VBX Stent Graft to bare metal stenting in patients with complicated iliac occlusive disease. The VBX Stent Graft provides accurate delivery and contributes to excellent outcomes in difficult aortoiliac applications.
   

The bare metal stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Self-expandable stent
• Balloon expandable stent

By Material Type, 2018 - 2032 (USD Million)

• Stainless steel stents
• Cobalt-chromium alloy stents
• Nitinol

By Application, 2018 - 2032 (USD Million)

• Coronary artery disease
• Peripheral artery disease
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA